Cytosorbents Corp. (NASDAQ: CTSO) reported Q1 EPS of ($0.19), $0.08 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $724 million versus the consensus estimate of $890 thousand.

For earnings history and earnings-related data on Cytosorbents Corp. (CTSO) click here.